INTRAJECT® Synovial Fluid Substitute in Accordance with TU 32.50.50-002-18527908-2019

INTRAJECT® Synovial Fluid Substitute in Accordance with TU 32.50.50-002-18527908-2019

The INTRAJECT® synovial fluid substitute, manufactured in accordance with TU 32.50.50-002-18527908-2019, is available in the following configurations:

• 1 ml volume in a 1 ml syringe, available concentrations (%): 1.0; 1.2; 1.4; 1.5; 1.8; 2.0; 2.1; 2.2
• 2 ml volume in a 2.25 ml syringe, available concentrations (%): 1.0; 1.2; 1.4; 1.5; 1.8; 2.0; 2.1; 2.2
• 3, 4, or 5 ml volume in a 5.25 ml syringe, available concentrations (%): 1.0; 1.2; 1.4; 1.5; 1.8; 2.0; 2.1; 2.2
• 6, 7, 8, 9, or 10 ml volume in a 10.25 ml syringe, available concentrations (%): 1.0; 1.2; 1.4; 1.5; 1.8; 2.0; 2.1; 2.2
• 3, 4, or 5 ml volume in a 5 ml vial, available concentrations (%): 1.0; 1.2; 1.4; 1.5; 1.8; 2.0; 2.1; 2.2
• 6, 7, 8, 9, or 10 ml volume in a 10 ml vial, available concentrations (%): 1.0; 1.2; 1.4; 1.5; 1.8; 2.0; 2.1; 2.2
• 15 or 20 ml volume in a 20 ml vial, available concentrations (%): 1.0; 1.2; 1.4; 1.5; 1.8; 2.0; 2.1; 2.2
• 25, 30, 35, 40, 45, or 50 ml volume in a 50 ml vial, available concentrations (%): 1.0; 1.2; 1.4; 1.5; 1.8; 2.0; 2.1; 2.2

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, INTRAJECT® Synovial Fluid Substitute in Accordance with TU 32.50.50-002-18527908-2019, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.